Axsome’s depression drug receives FDA approval
Yahoo Finance's Brian Cheung discusses reports that a depression drug from Axsome Therapeutics has gotten FDA clearance.
Video Transcript
BRIAN CHEUNG: All right well shares in Axsome Therapeutics, AXSM, our trending ticker this morning. That's after the FDA approved a drug to treat major depressive disorder in adults. A group expecting the rapid-acting oral medicine named Auvelity to become commercially available in the United States in the fourth quarter. Axsome says 21 million adults in the US experienced a major depressive disorder this year. Again, that news leading to the stock popping over 30% on this Friday morning.